{"id":10484,"date":"2013-01-25T08:49:03","date_gmt":"2013-01-25T08:49:03","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/research-and-markets-chronic-plaque-psoriasis-pipeline-review-h2-2012\/"},"modified":"2013-01-25T08:49:03","modified_gmt":"2013-01-25T08:49:03","slug":"research-and-markets-chronic-plaque-psoriasis-pipeline-review-h2-2012","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/psoriasis\/research-and-markets-chronic-plaque-psoriasis-pipeline-review-h2-2012\/","title":{"rendered":"Research and Markets: Chronic Plaque Psoriasis &#8211; Pipeline Review, H2 2012"},"content":{"rendered":"<p><p>    DUBLIN--(BUSINESS WIRE)--  <\/p>\n<p>    Research and Markets (<a href=\"http:\/\/www.researchandmarkets.com\/research\/tmwql4\/chronic_plaque\" rel=\"nofollow\">http:\/\/www.researchandmarkets.com\/research\/tmwql4\/chronic_plaque<\/a>)    has announced the addition of Global Markets Direct's new    report \"Chronic Plaque Psoriasis - Pipeline Review, H2 2012\" to    their offering.  <\/p>\n<p>    Global Markets Direct's, 'Chronic Plaque Psoriasis - Pipeline    Review, H2 2012', provides an overview of the indication's    therapeutic pipeline. This report provides information on the    therapeutic development for Chronic Plaque Psoriasis, complete    with latest updates, and special features on late-stage and    discontinued projects. It also reviews key players involved in    the therapeutic development for Chronic Plaque Psoriasis.  <\/p>\n<p>    Scope  <\/p>\n<p>    - A snapshot of the global therapeutic scenario for Chronic    Plaque Psoriasis.  <\/p>\n<p>    - A review of the Chronic Plaque Psoriasis products under    development by companies and universities\/research institutes    based on information derived from company and industry-specific    sources.  <\/p>\n<p>    - Coverage of products based on various stages of development    ranging from discovery till registration stages.  <\/p>\n<p>    - A feature on pipeline projects on the basis of monotherapy    and combined therapeutics.  <\/p>\n<p>    - Coverage of the Chronic Plaque Psoriasis pipeline on the    basis of route of administration and molecule type.  <\/p>\n<p>    - Key discontinued pipeline projects.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Link:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/research-markets-chronic-plaque-psoriasis-105700115.html;_ylt=A2KJjbz3RgJRuHUA3.r_wgt.\" title=\"Research and Markets: Chronic Plaque Psoriasis - Pipeline Review, H2 2012\">Research and Markets: Chronic Plaque Psoriasis - Pipeline Review, H2 2012<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> DUBLIN--(BUSINESS WIRE)-- Research and Markets (<a href=\"http:\/\/www.researchandmarkets.com\/research\/tmwql4\/chronic_plaque\" rel=\"nofollow\">http:\/\/www.researchandmarkets.com\/research\/tmwql4\/chronic_plaque<\/a>) has announced the addition of Global Markets Direct's new report \"Chronic Plaque Psoriasis - Pipeline Review, H2 2012\" to their offering. Global Markets Direct's, 'Chronic Plaque Psoriasis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chronic Plaque Psoriasis, complete with latest updates, and special features on late-stage and discontinued projects.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/psoriasis\/research-and-markets-chronic-plaque-psoriasis-pipeline-review-h2-2012\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-10484","post","type-post","status-publish","format-standard","hentry","category-psoriasis"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/10484"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=10484"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/10484\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=10484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=10484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=10484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}